PRELIMINARY PROGRAMME

Thursday, June 27th 2019

15:00-15:15 Welcome speech – Antonio Ceriello

15:15-17:00 Glycaemic variability and CV damage in diabetes
Chair: Eberhard Standl, Doina Catrinoiu
15:15-15:45 Variability of risk factors and diabetic complications
Antonio Ceriello (Milan – Italy)
15:45-16:15 Diagnostic approaches for diabetic cardiomiopathy
Irinel Raluca Parepa (Constanţa – Romania)
16:15-16:45 The impact on cardiovascular risk of antidiabetic medication: lessons learned from cardiovascular outcome trials.
Bogdan Timar (Timişoara – Romania)
16:45-17:00 Discussions

17:00-17:30 Coffee break

17:30-18:45 New perspectives in cardiovascular complications of diabetes
Chair: Laura Mazilu, Irinel Raluca Parepa
17:30-18:00 Cardiovascular implications of hypoglycemia in diabetes mellitus
Bogdan Mihai (Iaşi – Romania)
18:00-18:30 Cancer, diabetes and heart disease link
Laura Mazilu (Constanţa – Romania)
18:30-18:45 Discussions
18:45-19:15 MSD Symposium

19:15 Welcome reception

Friday, June 28th 2019

09:00-11:00 CV risk management in type 2 diabetes – new strategies
Chair: Jan Skrha, Baruch Itzhak
09:00-09:30 Glycaemic variability and CVD
Antonio Ceriello (Milan – Italy)
09:30-10:00 Are all GLP 1-RA the same on cardiovascular effects?
Nebojsa Lalic (Belgrade – Serbia)
10:00-10:30 SGLT-2 inhibition: a new therapeutic strategy in diabetes – preset the kidney?
Eugen Moţa (Craiova – Romania)
10:30-11:00 SGLT2 based treatments and cardiovascular effects
Romulus Timar (Timişoara – Romania)

11:00-11:30 Coffee break

11:30-13:45 Diabetic heart disease: what we know from guidelines and what we do in practice
Chair: Eberhard Standl, Dario Rahelic
11:30-12:00 The synthesis of multiple clinical trial inputs into guidelines and practice
Baruch Itzhak (Haifa – Israel)
12:00-12:30 Heart failure and diabetes
Maria Moţa (Craiova – Romania)
12:30-13:00 Heart failure in type 2diabetes – the „forgotten” complication
Cristian Guja (Bucharest – Romania)
13:00-13:30 Diabetes technology advances: the tool to fight against glycaemic variability
Doina Catrinoiu (Constanţa – Romania)
13:30-13:45 Discussions

13:45-14:45 Lunch break

14:45-17:00 Insulins in diabetes – how long, how fast?
Chair: Nebojsa Lalic, Antonio Ceriello
14:45-15:15 Ultra-long insulins
Paul Valensi (Paris – France)
15:15-15:45 Ultra-fast insulins
Dario Rahelic (Zagreb – Croatia)
15:45-16:15 Metformin and its benefits in improving gut microbiota disturbances in diabetes patients
Andra Suceveanu (Constanţa – Romania)
16:15-16:45 New perspectives of nutritional intervention in diabetic patients with cardiovascular disease
Anca Pantea Stoian (Bucharest – Romania)
16:45-17:00 Discussions

17:00-17:15 Coffee break

17:15-17:45 Sanofi Symposium

17:45-18:15 Eli Lilly Symposium

Saturday, June 29th 2019

09:00-11:15 New therapies in type 2 diabetes – moving beyond HbA1c and going to organ protection
Chair: Paul Valensi, Jan Skrha
09:00-09:30 Cardiac protection
Eberhard Standl (Munich – Germany)
09:30-10:00 Renal protection
Oliver Schnell (Munich – Germany)
10:00-10:30 Beta cell protection
Anca Cerghizan (Cluj-Napoca – Romania)
10:30-11:00 Hepatic protection
Eugen Dumitru (Constanţa – Romania)
11.00-11.15 Discussions

11:15-11:30 Coffee break

11:30-12:00 AstraZeneca Symposium

12:00-12:30 General Assembly